{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:31:13Z","timestamp":1744155073339},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2431-9-56","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T18:15:05Z","timestamp":1252606505000},"source":"Crossref","is-referenced-by-count":21,"title":["Incidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in Italy"],"prefix":"10.1186","volume":"9","author":[{"given":"Patrizio","family":"Pezzotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Benincori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Mucchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Di Lallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"287_CR1","first-page":"360","volume":"11","author":"JM Lozano","year":"2004","unstructured":"Lozano JM: Bronchiolitis. Clinical Evidence. 2004, 11: 360-374.","journal-title":"Clinical Evidence"},{"key":"287_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(06)69077-6","volume":"368","author":"RL Smyth","year":"2006","unstructured":"Smyth RL, Openshaw PJ: Bronchiolitis. Lancet. 2006, 368: 312-22. 10.1016\/S0140-6736(06)69077-6.","journal-title":"Lancet"},{"key":"287_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/thx.51.Suppl_2.S60","volume":"51","author":"S Godfrey","year":"1996","unstructured":"Godfrey S: Bronchiolitis and asthma in infancy and early childhood. Thorax. 1996, 51: 560-4. 10.1136\/thx.51.Suppl_2.S60.","journal-title":"Thorax"},{"key":"287_CR4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/pch\/8.10.631","volume":"8","author":"J Langley","year":"2003","unstructured":"Langley J, for the Infectious Diseases and Immunization Committee of the Canadian Pediatric Society: Use of palivizumab in children with congenital disease. Paediatr Child Health. 2003, 8: 631-33.","journal-title":"Paediatr Child Health"},{"key":"287_CR5","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1067\/S0022-3476(03)00508-0","volume":"143","author":"RC Welliver","year":"2003","unstructured":"Welliver RC: Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003, 143: S112-7. 10.1067\/S0022-3476(03)00508-0.","journal-title":"J Pediatr"},{"key":"287_CR6","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1067\/S0022-3476(03)00511-0","volume":"143","author":"EA Simoes","year":"2003","unstructured":"Simoes EA: Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003, 143: S118-26. 10.1067\/S0022-3476(03)00511-0.","journal-title":"J Pediatr"},{"key":"287_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/01.inf.0000108188.37237.48","volume":"23","author":"KJ Henrickson","year":"2004","unstructured":"Henrickson KJ, Hoover S, Kehl KS, Hua W: National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004, 23: S11-8. 10.1097\/01.inf.0000108188.37237.48.","journal-title":"Pediatr Infect Dis J"},{"key":"287_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"Impact-RSV study group","year":"1998","unstructured":"Impact-RSV study group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998, 102: 531-537. 10.1542\/peds.102.3.531.","journal-title":"Pediatrics"},{"key":"287_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","volume":"143","author":"TF Feltes","year":"2003","unstructured":"Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH, Connor EM, Sondheimer HM, Cardiac Synagis Study Group: Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003, 143: 532-540. 10.1067\/S0022-3476(03)00454-2.","journal-title":"J Pediatr"},{"key":"287_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","volume":"102","author":"American Academy of Pediatrics, Committee of infectious Diseases and Committee on Fetus and Newborn","year":"1998","unstructured":"American Academy of Pediatrics, Committee of infectious Diseases and Committee on Fetus and Newborn: Prevention of respiratory syncitial virus infections: indications for the use of palivizumab and update on the use of VRSIGIV. Pediatrics. 1998, 102: 1211-1216. 10.1542\/peds.102.5.1211.","journal-title":"Pediatrics"},{"key":"287_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","volume":"112","author":"American Academy of Pediatrics, Committee of infectious Diseases and Committee on Fetus and Newborn","year":"2003","unstructured":"American Academy of Pediatrics, Committee of infectious Diseases and Committee on Fetus and Newborn: Revised indications for the use of palivizumab and respiratory syncitial virus immune globulin intravenous for the prevention of respiratory syncitial virus infections. Pediatrics. 2003, 112: 1442-1446. 10.1542\/peds.112.6.1442.","journal-title":"Pediatrics"},{"key":"287_CR12","first-page":"1","volume":"1","author":"Societ\u00e0 Italiana di Neonatologia","year":"2004","unstructured":"Societ\u00e0 Italiana di Neonatologia: Raccomandazioni della Societ\u00e0 Italiana di Neonatologia per la prevenzione delle malattie da virus respiratorio sinciziale (VRS). Aggiornamento. 2004, 1: 1-11.","journal-title":"Aggiornamento"},{"key":"287_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/00006454-200206000-00007","volume":"21","author":"PI Oh","year":"2002","unstructured":"Oh PI, Lanctjt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P, Composs Investigators: Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes. Pediatr Infect Dis J. 2002, 21: 512-8. 10.1097\/00006454-200206000-00007.","journal-title":"Pediatr Infect Dis J"},{"key":"287_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/00006454-200306000-00010","volume":"22","author":"R Singleton","year":"2003","unstructured":"Singleton R, Dooley L, Bruden D, Raelson S, Butler JC: Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J. 2003, 22: 540-545. 10.1097\/00006454-200306000-00010.","journal-title":"Pediatr Infect Dis J"},{"key":"287_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","volume":"22","author":"C Pedraz","year":"2003","unstructured":"Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, Quero J, IRIS Study Group: Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J. 2003, 22: 823-827. 10.1097\/01.inf.0000086403.50417.7c.","journal-title":"Pediatr Infect Dis J"},{"key":"287_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.inf.0000105106.93562.d3","volume":"23","author":"E Henckel","year":"2004","unstructured":"Henckel E, Luthander J, Berggren E, Kapadia H, Naver L, Norman M, Bennet R, Eriksson M: Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002. Pediatr Infect Dis J. 2004, 23: 27-31. 10.1097\/01.inf.0000105106.93562.d3.","journal-title":"Pediatr Infect Dis J"},{"key":"287_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ppul.20503","volume":"42","author":"M Grimaldi","year":"2007","unstructured":"Grimaldi M, Gouyon B, Sagot P, Quantin C, Huet F, Gouyon JB, Burgundy Perinatal Network: Palivizumab efficacy in preterm infants with gestational age < or = 30 weeks without bronchopulmonary dysplasia. Pediatr Pulmonol. 2007, 42: 189-192. 10.1002\/ppul.20503.","journal-title":"Pediatr Pulmonol"},{"key":"287_CR18","first-page":"76","volume":"20","author":"D Agostini","year":"1996","unstructured":"Agostini D, Chiappa G, Gasperini AM, Stefanelli P: The quality of the data on the certificate of delivery care. Epidemiol Prev. 1996, 20: 76-9.","journal-title":"Epidemiol Prev"},{"key":"287_CR19","first-page":"339","volume":"60","author":"AM Di Paolo","year":"2008","unstructured":"Di Paolo AM, Fumu L, Minelli L, Di Renzo GC: The birth certificate as an instrument for pregnancy. Minerva Ginecol. 2008, 60: 339-344.","journal-title":"Minerva Ginecol"},{"key":"287_CR20","first-page":"21","volume":"18","author":"A Di Napoli","year":"2005","unstructured":"Di Napoli A, Pezzotti P, Di Lallo D, Tancioni V, Papini P, Guasticchi G: Determinants of hospitalization in a cohort of chronic dialysis patients in central Italy. J Nephrol. 2005, 18: 21-29.","journal-title":"J Nephrol"},{"key":"287_CR21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/039463200802100422","volume":"21","author":"M Calvani","year":"2008","unstructured":"Calvani M, Di Lallo D, Polo A, Spinelli A, Zappala D, Zicari M: Hospitalizations for pediatric anaphylaxis. Int J Immunopathol Pharmacol. 2008, 21: 977-983.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"287_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/jbin.2002.1036","volume":"34","author":"L Dal Maso","year":"2001","unstructured":"Dal Maso L, Braga C, Franceschi S: Methodology used for \"software for automated linkage in Italy\" (SALI). J Biomed Inform. 2001, 34: 387-395. 10.1006\/jbin.2002.1036.","journal-title":"J Biomed Inform"},{"key":"287_CR23","doi-asserted-by":"publisher","first-page":"F64","DOI":"10.1136\/adc.2003.029710","volume":"90","author":"T Heikkinen","year":"2005","unstructured":"Heikkinen T, Valkonen H, Lehtonen L, Vainionpaa R, Ruuskanen O: Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed. 2005, 90: F64-F68. 10.1136\/adc.2003.029710.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"287_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1017\/S0950268807000180","volume":"136","author":"K Grimwood","year":"2008","unstructured":"Grimwood K, Cohet C, Rich FJ, Cheng S, Wood C, Redshaw N, Cunningham CW, Pearce N, Kirman JR: Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect. 2008, 136: 1333-41. 10.1017\/S0950268807000180.","journal-title":"Epidemiol Infect"},{"key":"287_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/aje\/kwm165","volume":"166","author":"Z Fewell","year":"2007","unstructured":"Fewell Z, Davey Smith G, Sterne JA: The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007, 166: 646-55. 10.1093\/aje\/kwm165.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-9-56\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-9-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-9-56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-9-56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:45:19Z","timestamp":1548189919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-9-56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-9-56","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]},"article-number":"56"}}